Skin of Color Update 30% Off Registration, Use Code: JDD30
Skip to main content
JDD HighlightsJDD in the MediaThe Latest

JDD in the News: Chlorophyll for Clear Skin, Depression & Isotretinoin

By May 26, 2021July 15th, 2021No Comments

In The News

In the News

JDD Impact Factor and Influence

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll.

More on Chlorophyll

The Journal of Drugs in Dermatology in the News 

Allison Sit

The Journal of Drugs in Dermatology is featured in two recent articles about the latest TikTok trend — chlorophyll. Users claim products that contain chlorophyllin – a water-soluble version of chlorophyll — clear the skin, reduce bloating and help with weight loss. Both articles, “Liquid Chlorophyll: What to Know Before Buying,” by NBC News, and “Should You Hop on the Chlorophyll Wellness Trend?” by L’Officiel address the nutritional benefits of chlorophyll and ways to consume more of it.

The articles both cite a 2015 JDD study, “Pilot Study of Topical Copper Chlorophyllin Complex in Subjects With Facial Acne and Large Pores,” by Thomas J. Stephens, PhD, John P. McCook, and Dr. James H. Herndon, Jr. The study found a topical formulation containing a liposomal dispersion of sodium copper chlorophyllin complex to be clinically effective and well tolerated for the treatment of mild to moderate acne and large, visible pores when used for 3 weeks.

Dermatology Times highlighted a JDD study in its article, “Depression, Distress Different Between Patients Treated with Isotretinoin and Oral Antibiotics.” The article cites a February 2021 study, “Differences in Depression and Distress Between Acne Patients on Isotretinoin vs Oral Antibiotics” by Dr. April Armstrong and researchers. The study analyzed acne patients’ responses to Patient Health Questionnaire 2 and the Kessler 6-Item Psychological Distress Scale. Researchers found acne patients on isotretinoin experienced fewer depressive symptoms and psychological distress compared to patients on oral antibiotics.

The Dermatology Digest also wrote about the JDD study on depression and isotretinoin in its April print edition. The publication also published briefs on two other 2021 JDD articles, “Laboratory Testing in Telogen Effluvium,” and “Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.”

You May Also Like

APP-solutely Essential: Putting Corticosteroid Stewardship Into Practice

| Featured Articles, Featured Podcast, Latest News, Podcast, Podcast Highlights | No Comments
Guest: Douglas DiRuggiero  Corticosteroids remain one of dermatology’s most reliable workhorses, but good stewardship isn’t about putting the horse out to pasture. It’s about knowing when to ride, when to…
Journal of Drugs in Dermatology JDD featuring Topical Carboxytherapy as an Adjunct to Skin Recovery Post-CO2 Laser Fractional Resurfacing

Topical Carboxytherapy as an Adjunct to Skin Recovery Post-CO2 Laser Fractional Resurfacing

| Aesthetics, Featured Articles, Lasers & Light Devices, Latest News | No Comments
Post-Procedure Optimization: Enhancing Laser Resurfacing Outcomes With Topical Carboxytherapy  Have you read this recent article from the JDD regarding post-laser skin recovery protocols? As aesthetic dermatology continues to advance, optimizing…
Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of tinea versicolor among different skin tones

Tune In to Clinical Innovation: Celebrating National Podcast Day with the JDD Podcast

| Featured Articles, Featured Podcast, Latest News | No Comments
Join JDD Podcast: Ask the Investigators as we celebrate a decade of dermatology insight with our trusted host, Dr. Adam Friedman National Podcast Day provides the perfect opportunity to highlight…

Leave a Reply